TGA holds off publicising decision on the rescheduling of nitrous oxide
Publication of the TGA scheduling committee’s interim decision and invitation to comment on a rescheduling proposal for nitrous oxide (Nangs) has been delayed.
The interim decision was not announced on 20 July when the TGA issued the public notice of interim decisions from the March 2021 joint meeting of the Advisory Committee on Medicines Scheduling/Advisory Committee on Chemical Scheduling (ACMS/ACCS).
“The interim decision for nitrous oxide is anticipated for publication by the end of July,” the TGA said.
The proposal application is to create a new Schedule 10 entry for nitrous oxide for non-therapeutic purposes “except when included in Schedule 4, or supplied in containers greater than 50cm³ or supplied in a gaseous alone in 10g or greater quantity”.
Nitrous Oxide is included in Schedule 4 for “human therapeutic use”.
Nitrous oxide, also known as laughing gas,, or by the slang term ‘nangs’ is an anaesthetic that has been used for more than 100 years.
The availability and anaesthetic properties of nitrous oxide lend it to notable misuse, with heavy users capable of consuming the contents of hundreds of canisters per session, the TGA said.
Click here for an AJP article explaining the misuse of nitrous oxide